共 50 条
- [41] IDH1 and IDH2 mutations in pediatric acute leukemiaLEUKEMIA, 2011, 25 (10) : 1570 - 1577Andersson, A. K.Miller, D. W.Lynch, J. A.Lemoff, A. S.Cai, Z.Pounds, S. B.Radtke, I.Yan, B.Schuetz, J. D.Rubnitz, J. E.Ribeiro, R. C.Raimondi, S. C.Zhang, J.Mullighan, C. G.Shurtleff, S. A.Schulman, B. A.Downing, J. R.
- [42] IDH-mutant glioma: A new IDH1 inhibitor moves forwardNEURO-ONCOLOGY, 2023, 25 (02) : 337 - 338Miller, Julie J.Arrillaga-Romany, Isabel
- [43] The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient derived xenograft (PDX) modelCANCER RESEARCH, 2016, 76Machida, YukinoOgawara, YokoIchimura, KoichiMatsunaga, HironoriTakahiko, SekiAraki, KazushiKitabayashi, Issay
- [44] Mutant IDH1 and thrombosis in gliomasActa Neuropathologica, 2016, 132 : 917 - 930Dusten UnruhSteven R. SchwarzeLaith KhouryCheddhi ThomasMeijing WuLi ChenRui ChenYinxing LiuMargaret A. SchwartzChristina AmideiPriya KumthekarCarolina G. BenjaminKristine SongCaleb DawsonJoanne M. RispoliGirish FatterpekarJohn G. GolfinosDouglas KondziolkaMatthias KarajannisDonato PacioneDavid ZagzagThomas McIntyreMatija SnuderlCraig Horbinski
- [45] CHARACTERIZATION OF MUTANT IDH1 OLIGODENDROGLIOMASNEURO-ONCOLOGY, 2019, 21 : 263 - 263Heinz, RickHolmen, Sheri
- [46] Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S217 - S218DiNardo, Courtney D.Stein, Anthony S.Stein, Eytan M.Fathi, Amir T.Frankfurt, OlgaSchuh, Andre C.Doehner, HartmutMartinelli, GiovanniRaffoux, EmmanuelTan, PeterZeidan, Amerde Botton, StephaneKantarjian, Hagop M.Stone, Richard M.Lam, DuWang, XiweiGong, JingKapsalis, Stephanie M.Hickman, DeniceZhang, VickieWinkler, ThomasDaigle, ScottVyas, Paresh
- [47] Mutant IDH1 and thrombosis in gliomasACTA NEUROPATHOLOGICA, 2016, 132 (06) : 917 - 930Unruh, DustenSchwarze, Steven R.Khoury, LaithThomas, CheddhiWu, MeijingChen, LiChen, RuiLiu, YinxingSchwartz, Margaret A.Amidei, ChristinaKumthekar, PriyaBenjamin, Carolina G.Song, KristineDawson, CalebRispoli, Joanne M.Fatterpekar, GirishGolfinos, John G.Kondziolka, DouglasKarajannis, MatthiasPacione, DonatoZagzag, DavidMcIntyre, ThomasSnuderl, MatijaHorbinski, Craig
- [48] Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant CancersACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (04): : 300 - 305Popovici-Muller, JanetaLemieux, Rene M.Artin, ErinSaunders, Jeffrey O.Salituro, Francesco G.Travins, JeremyCianchetta, GiovanniCai, ZhenweiZhou, DingCui, DaweiChen, PingStraley, KimberlyTobin, EricaWang, FangDavid, Muriel D.Penard-Lacronique, VirginieQuivoron, CyrilSaada, VeroniqueDe Botton, StephaneGross, StefanDang, LennyYang, HuaUtley, LukeChen, YueKim, HyeryunJin, ShengfangGu, ZhiweiYao, GuiLuo, ZhiyongLv, XiaobingFang, ChengYan, LipingOlaharski, AndrewSilverman, LeeBiller, ScottSu, Shin-San M.Yen, Katharine
- [49] Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Dinardo, Courtney DentonStein, Anthony SelwynStein, Eytan M.Fathi, Amir TahmasbFrankfurt, OlgaSchuh, Andre C.Martinelli, GiovanniPatel, Prapti ArvindRaffoux, EmmanuelTan, PeterZeidan, Amer Methqalde Botton, StephaneKantarjian, Hagop M.Stone, Richard M.Lam, Du HungGong, JingZhang, VickieWinkler, ThomasWu, BinVyas, Paresh
- [50] NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutationLEUKEMIA & LYMPHOMA, 2021, 62 (07) : 1790 - 1792Raman, Hari S.Shanmugam, VigneshLi, JingweiSteensma, David P.Kim, Annette S.Luskin, Marlise R.